The Pharmacy Guild’s NSW branch wants to know how the codeine upschedule has impacted pharmacists and their patients
Pharmacists have been invited to ask their patients to participate in the consumer impact survey, which is aimed at assessing the economic, clinical and humanistic impacts of the rescheduling of low-dose codeine to Prescription Only.
“We just want to get some feedback from consumers, to measure what they’re doing – whether they’re going to get prescriptions [for codeine-containing analgesics], how much they’re out of pocket, and how they find it in terms of convenience,” NSW branch president David Heffernan says.
“We want to get a decent sort of sample size so that it’s reasonably significant, and measure that need – and if there are issues, look at addressing them.”
The Guild’s NSW Branch is also asking pharmacists to talk to it about any incidents or complications that have been experienced in-store due to the scheduling change.
“Examples may include patients being unable to conveniently access their doctor, those who have suffered unnecessary pain, or any instances of adverse behaviour or frustration from the change,” the Guild says in a message to members.
“We would also like to receive information regarding the impact on doctors prescribing in your area and how they are treating people with acute pain.”
The survey is open until Friday 20 July 2018.